Transformative advances in drug treatments approved by the Food and
Drug Administration are giving the 3.2 million Americans with chronic
hepatitis C a chance for a longer, healthier life without the virus.
That’s welcome news for baby boomers—who make up three of four adults
with the hepatitis C virus—and millions of other Americans, many of whom
don’t yet know they are infected and carriers.
Hepatitis C can
be cured, and today’s drug therapies are very effective and easier for
patients to take, says Jeffrey S. Murray, M.D., the deputy director of
the Division of Antiviral Products in FDA’s Center for Drug Evaluation
and Research. Murray is an internist who specializes in infectious